Presented at the American Society for Clinical Oncology Annual Meeting, Chicago, IL, June 2011.
Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients
A Report from the Children's Oncology Group
Version of Record online: 19 SEP 2013
© 2013 American Cancer Society
Volume 119, Issue 23, pages 4162–4169, 1 December 2013
How to Cite
Canner, J., Alonzo, T. A., Franklin, J., Freyer, D. R., Gamis, A., Gerbing, R. B., Lange, B. J., Meshinchi, S., Woods, W. G., Perentesis, J. and Horan, J. (2013), Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients. Cancer, 119: 4162–4169. doi: 10.1002/cncr.28342
See related article on pages 4170–9, this issue.
- Issue online: 18 NOV 2013
- Version of Record online: 19 SEP 2013
- Manuscript Accepted: 15 JUL 2013
- Manuscript Revised: 28 JUN 2013
- Manuscript Received: 7 MAY 2013
- 8Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10).Adult and Childhood Leukaemia Working Parties of the Medical Research Council. Blood. 1997;89:2311–2318., , , et al.
- 10Actue Myeloid Leukemia (AML) in adolescents and young adults (AYAs): a comparison of outcomes between patients treated on childhood or adult protocols. Blood. 2001;98(abstract 1934)., , .
- 19Treatment toxicity in adolescents and young adult (AYA) patients compared with younger patients treated for high risk B-precursor acute lymphoblastic leukemia (HR-ALL): a report from the Children's Oncology Group Study AALL0232. Blood. 2011;118;Abstract 1510., , , et al.